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symptoms or signs of pulmonary or systemic TB were
found. Of the 125 patients with CNS TB, 9 (7.2%) pre-
sented with clinical and radiological features suggestive of
a brain tumour.
Results: A diagnosis of tuberculoma was established either
intraoperatively in frozen sections (three patients) or post-
operatively when the masses were resected (six patients).
After surgery, seven patients recovered after receiving
anti-TB treatment; one patient died, and another developed
a severe neurological deficit.
Conclusion: CNS TB is a great mimicker of brain tumours,
and the index of suspicion should be high, especially in
endemic areas. A diagnosis is based on clinical presentation
and the results of investigations. In patients with CNS TB
that present with a mass lesion, a biopsy should be taken
to avoid morbidity and mortality from an unnecessary sur-
gical intervention.
Greater use should be made of magnetic resonance spec-
troscopy in the evaluation of brain space-occupying lesions,
and CNS TB should be included in the differential diagnosis
of such lesions in all areas endemic for TB. The absence of
constitutional or pulmonary symptoms of TB is deceiving.
More nationwide epidemiological studies are needed to
establish guidelines for early detection and successful out-
comes of this rising health problem.
Keywords: Brain space-occupying lesions; Brain tumour; Cere-
bral mass; CNS tuberculosis
 2014 Taibah University. Production and hosting by Elsevier
Ltd. All rights reserved.
Introduction
Although tuberculosis (TB) is a curable disease, it is the
world’s second commonest cause of death from infectious dis-
ease, the first being infection with human immune deficiency
virus (HIV). The World Health Organization (WHO) esti-
mated that nearly one third (1.9 billion people) of all the peo-
ple in the world are infected with Mycobacterium tuberculosis,
and it has probably killed more than 100 million people over
the past 100 years.1 It is endemic in most developing countries
and is resurgent in countries with high rates of HIV infection.2
In the Kingdom of Saudi Arabia, according to WHO, the inci-
dence of smear-positive TB and deaths from TB each rose by
6.2% between 1990 and 2004.
Although 85% of cases of TB occur in the lungs, 15% occur
outside the respiratory system, the central nervous system
(CNS) being the second commonest site of involvement.3
CNS TB accounts for approximately 1% of all of disease
caused by M. tuberculosis and carries the worst prognosis of
any other form.4 Tuberculous meningitis, the commonest form
of CNS TB, may result in hydrocephalus, brain infarction and
death if left untreated.4 CNS TB can present either as diffuse
forms, such as basal exudative meningitis, or as localized
forms, such as tuberculoma, abscess or cerebritis.
Tuberculomas are the commonest manifestation of paren-
chymal TB. They can occur at any age and can be solitary
or multiple.5 Tuberculomas may affect the brain (meningeal,
parenchymal or ependymal), spinal cord, subarachnoid, sub-
dural or epidural space. Cerebral tuberculomas can occur any-
where in the brain parenchyma but are usually located at the
corticomedullary junction and periventricular region, as ex-
pected for haematogenous dissemination. In children, they
predominate in the infratentorial compartment, whereas in
adults, the supratentorial compartment is more commonly
affected.6 Rarely, they are found within the ventricle (the lat-
eral ventricle being the commonest site), the cavernous sinus,
the sella turcica, the hypophysis, the hypothalamus, the sphe-
noid sinus or mastoid air cells.7 The frontal and parietal lobes
are the most commonly affected regions, especially on the left,
probably due to greater blood flow to the dominant hemi-
sphere.8 Tuberculomas arise when tubercles in the parenchyma
of the brain enlarge without rupturing into the subarachnoid
space. They usually occur in the absence of meningitis, but
they may coexist because of extension of cerebrospinal fluid
infection into the adjacent parenchyma via cortical veins or
Virchow-Robin spaces.9 Tuberculomas consist of epithelioid
cells and giant cells mixed with lymphocytic inflammatory
cells, forming a non-caseating granuloma. It subsequently
develops a central area of caseating necrosis, which is initially
solid and may liquefy later.
Patients usually present with headache, seizures, fever, focal
neurological deficit and features of raised intracranial pressure.
Infratentorial tuberculomas may present with brainstem syn-
dromes, cerebellar symptoms and multiple cranial nerve
palsy.9,10 Clinical findings suggestive of extraneural TB are fre-
quently subtle or absent, and fewer than 50% of patients have
a history of TB. In patients with CNS tuberculoma, typical
cerebrospinal fluid findings might be absent,11 and immuno-
logical studies and adenosine deaminase are neither specific
nor sensitive; culture and PCR are specific but not sensitive.
Tuberculomas can present as space-occupying lesions that
are indistinguishable from brain neoplasms. Although cancer
treatments are frequently toxic, the risk of toxic effects is jus-
tified by the potential gains in survival seen when the appropri-
ate treatment is assigned to the right patient. The aim of the
study reported here was to find signs to differentiate CNS
tuberculomas from brain tumours by reviewing all cases seen
at our institute over a 10-year period.
Materials and Methods
We conducted a retrospective chart review of all cases of CNS
TB seen at the King Abdulaziz Medical City, Jeddah, between
January 2002 and January 2012. A total of 125 patients were
identified. While most presented with either tuberculous men-
ingitis or tuberculoma, nine (7.2%) presented with clinical and
radiological features suggestive of a brain tumour. A diagnosis
was established either intraoperatively from frozen sections
(three patients) or postoperatively when the masses were
resected (six patients).
Results
No symptoms or signs of pulmonary or systemic TB were
found. One patient died, and another patient developed a
severe neurological deficit. The remaining patients recovered
after receiving anti-TB treatment. None of the cases was tested
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for HIV infection, even after the diagnosis was established.
Magnetic resonance spectroscopy (MRS) was used for only
one patient, and the result suggested a diagnosis of brain tu-
mour rather than CNS TB. Less favourable outcomes were
seen in an elderly patient, in cases of posterior fossa TB and
in patients who underwent complete resection of the mass.
Table 1 shows the clinical and radiological features and
outcomes of the nine cases.
Patient 1
A 27-year-old male presented with headache of 8 months’
duration, which was of moderate severity and felt mostly over
the occipital region; the pain responded to over-the-counter
medication. He had no history of vomiting, seizures, loss of
consciousness, fever, weight loss, cough, weakness or sensory
symptoms. He also complained of diminished vision in his
both eyes and drowsiness that started 1 month before presen-
tation. He had sought medical attention because of the visual
symptoms. He had type 2 diabetes mellitus, which was being
treated with metformin and gliclazide. His uncle had been trea-
ted for TB a long time previously. On physical examination,
the patient was found to be obese, with a blood pressure of
150/70 mm Hg and normal temperature. His higher mental
functions were normal. He had decreased visual acuity in both
eyes (6/60 bilaterally), with right homonymous haemianopia.
Fundoscopy showed bilateral chronic papilloedema. The
remaining cranial nerves were normal. Motor, sensory and
coordination examinations were normal. There was no sign
of meningeal irritation. Computed tomography (CT) of the
brain revealed a left occipital hypodense lesion measuring
3.5  3.5 cm with surrounding oedema, enhanced after con-
trast, which was highly suggestive of a meningioma. There
was a midline shift of 1.1 cm, with compression of the left lat-
eral ventricle. MRI of the brain confirmed the findings of the
CT scan (Figure 1), and MRS was highly suggestive of a tu-
mour (Figure 2). Complete blood count, renal function and
electrolyte tests were normal. The erythrocyte sedimentation
rate was 55 mm during the first hour, and the C-reactive pro-
tein value was 30. A chest X-ray was normal. After his blood
sugar was controlled, he received dexamethasone and was pre-
pared for surgery 3 weeks later for a possible biopsy. The lesion
was found to be intra-axial with outside attachment to the dura.
A frozen section indicated a tuberculoma, which was totally ex-
cised. Histopathological examination showed a necrotizing
granulomatous lesion (Figure 3), which was positive for acid-
fast bacilli. The infectious disease team reviewed the patient
and started him on a four-drug anti-TB regimen. He was found
to be positive for M. tuberculosis and was fully sensitive to the
medications. On follow up, the patient was found to have im-
proved markedly, and after 2 months, ethambutol and pyriza-
mide were discontinued; he was advised to continue with
rifampicin and isoniazid to complete the course of 1 year.
Patient 2
A 62-year-old male presented with headache, confusion,
slurred speech and gait disturbance of 2 weeks’ duration. He
had no history of fever, cough or weight loss but was a known
case of type 2 diabetes mellitus and hypertension, which were
being treated. He had no family history of exposure to TB.
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Physical examination revealed right hemiparesis and expressive
aphasia. MRI of the brain revealed a left frontoparietal mass
with surrounding oedema and a midline shift, which was diag-
nosed as a glioma multiforme. He was treated with steroids.
Figure 1: MRI of the brain of patient 1. T2-weighted (A) and FLAIR (B) images show high signal intensity in the left temporo-parieto-
occipital region with surrounding oedema. Post-gadolinium axial (C) and sagittal (D) views show enhancement.
Figure 2: MRS of patient 1 is highly suggestive of a tumour.
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After 3 days, he was sent to surgery, and the mass was re-
sected. Histopathological examination revealed a tuberculoma.
He was started on anti-TB treatment and phenytoin. He
improved clinically and was discharged after 6 weeks. He com-
pleted the prescribed course of treatment and was examined
clinically 6 months later. He had no neurological deficit, apart
from mild expressive aphasia.
Patient 3
A 75-year-old woman presented with a 5-day history of nau-
sea, gait disturbance and left side weakness. She had no history
of fever, headache or seizures. The only significant feature of
her medical history was hypertension. On physical examina-
tion, her consciousness level was found to be depressed, with
a Glasgow coma stage score of 7/15, flexing all her limbs to
painful stimuli and the left side moving less than the right.
Her blood pressure was 180/86 mm Hg, her temperature was
normal, and no cranial nerve palsy was apparent. Both plan-
tars were upgoing. CT scan of the brain showed a large hypo-
dense area covering both cerebellar hemispheres and the
vermis, with a mass effect on the fourth ventricle and the
brainstem, mainly on the right side. MRI of the brain revealed
a right cerebellar mass with surrounding oedema and hydro-
cephalus. A biopsy from the cerebellar mass was consistent
with a tuberculoma. The patient was started on anti-TB treat-
ment and made a complete recovery.
Patient 4
A 72-year-old man presented with a 4-month history of recur-
rent episodes of twitching on the left side of the face. One
month previously, he had noted weakness of the left side of
the body involving the face, arm and leg. CT of the brain at
a local hospital showed a hypodense area in the region of
the right middle cerebral artery, suggestive of infarction.
MRI of the brain revealed a right parieto-occipital ring-
enhancing nodule with well-defined margins and surrounding
oedema, suggesting a glioblastoma multiforme. The patient
was transferred to our hospital, and a biopsy was performed.
Histopathology showed a caseating granuloma with a positive
acid-fast bacilli stain. Work-up for systemic disease, including
chest radiography and a CT scan, was negative. He was started
on anti-TB treatment and recovered fully. A follow-up MRI
scan 6 months later showed significant regression of the lesion.
Patient 5
An 82-year-old man was admitted from the emergency room
complaining of vomiting, dizziness and unsteady gait of
1 month’s duration. He had been operated on at another hos-
pital 6 months previously to remove a cerebellar mass, which
was reported to be a low-grade glioma. On physical examina-
tion, he was found to have cerebellar signs and ataxic gait. CT
of the brain was repeated and showed a right cerebellar mass
with enhancement and surrounding oedema. He underwent
craniotomy and excision of the cerebellar mass. Histopathol-
ogy revealed a tuberculoma, and anti-TB treatment was
started. Unfortunately, he developed multiple postoperative
complications, including subglial collection at the surgery site,
hospital-acquired pneumonia, acute respiratory distress syn-
drome and multiorgan failure, and died after 52 days.
Patient 6
A 41-year-old man presented with progressive headache of
4 months’ duration, which had increased in severity and
was associated with dizziness and vomiting. He was admitted
to the local hospital, and CT of the brain revealed a left fron-
tal lesion (4  3.7 cm). Although a biopsy was performed, the
result was inconclusive, and the patient was referred to our
hospital. He had no medical history of significant illness.
Physical examination revealed a Glasgow coma scale score
of 11/15 and right-side hemiparesis. Biopsy was repeated,
and the results were consistent with CNS TB. Treatment with
anti-TB drugs markedly improved his neurological status. By
the time of discharge, 1 month after starting treatment, he
was mobile with support and was independent in his daily
activities. He followed the course of anti-TB treatment for
18 months and had apparently complete recovery. A follow-
up MRI of the brain showed regression of the lesion to
1.6  1.9 cm.
Patient 7
A 14-year-old girl presented with a 4-week history of progres-
sive headache that did not respond to analgesics. She had no
history of fever, weight loss or seizures, and her medical his-
tory was unremarkable. She had no history of contact with
TB. Systemic and neurological examinations and routine
blood investigations and chest radiography were normal. CT
and MRI of the brain showed a right fronto-parietal mass with
Figure 3: Histopathology result for patient 1 consistent with a granuloma.
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surrounding oedema, suggesting a brain tumour. Her family
elected to take her abroad for a second opinion and further
management. She underwent complete resection of the mass,
and histopathology showed TB, and she was started on anti-
TB treatment. Unfortunately, she developed left-side dense
hemiplegia and refractory seizures and is now taking three
antiepileptic drugs.
Patient 8
A 50-year-old woman presented with a 3-month history of
twitching movements on the right side of her face, which had
worsened during the past 2 weeks. She had no constitutional
symptoms, and her medical history was unremarkable. MRI
of the brain was performed at a local hospital, where the diag-
nosis was a brain tumour. She was started on tegretol and
dexamethasone and came to our hospital for further manage-
ment. General and neurological examinations were normal.
MRI of the brain at our hospital revealed a left frontal mass
measuring 2  2 cm with surrounding oedema, suggestive of
a high-grade glioma with metastases. Work-up for systemic
malignancy and infections, including TB, was negative. Four
days later, she underwent craniotomy and total resection of
the mass. She had aphasia immediately post-operatively, which
subsequently improved. Histopathology and culture were con-
sistent with TB. She completed a course of 12 months of anti-
TB treatment and had recovered completely when seen
18 months later.
Patient 9
A 26-year-old man with no known chronic illness came to the
neurosurgical clinic complaining of progressive headache of
1 year’s duration, associated with two episodes of tonic–clonic
seizures and decreased visual acuity within the previous
2 weeks. He had no history of weakness, fever, weight loss or
night sweating. Physical examination revealed normal vital
signs and higher mental function but decreased visual acuity
and bilateral chronic papilloedema. MRI of the brain showed
a right tempero-parietal enhancing lesion with surrounding oe-
dema causing a mass effect (Figure 4). He was started on dexa-
methasone and phenytoin and one week later underwent right
tempero-parietal craniotomy and total excision of the mass,
with no complications. Frozen section and histopathology re-
ports confirmed a diagnosis of tuberculoma. He was started on
anti-TB therapy after assessment and evaluation by the infec-
tious disease team. He improved gradually and was completely
normal 6 months later.
Discussion
On CT, tuberculomas are either round or lobulated, with a
variable appearance, and may appear hypo- or hyperdense to
the brain parenchyma. Caseating granulomas show homoge-
neous contrast enhancement enhanced peripherally.8,9 Moder-
ate-to-marked peri-lesional oedema is frequent. In rare cases, a
ring-enhancing lesion with a hypodense centre may reveal cen-
tral calcification. This is known as the ‘target sign’ and,
although considered characteristic of tuberculoma by some
authors, others consider it to be nonspecific and therefore lead-
ing to erroneous diagnoses.13
MRI findings of a tuberculoma vary according to the stage
and location of the lesion. They appear as isointense to grey
matter on T1-weighted images and may have a slightly hyper-
intense rim. Noncaseating lesions are bright on T2-weighted
images, with nodular enhancement. Caseating tuberculomas
vary from isointense to hypointense on T2-weighted images
and also exhibit rim enhancement. They may have a variable
degree of mass effect and perilesional oedema, which is usually
more prominent in the early stages.8,9,14
Although MRS may be helpful in differentiating tubercu-
lomas from other space-occupying lesions, they are com-
monly indistinguishable from brain tumours or infections
such as neurocysticercosis. MRS shows a prominent decrease
in the ratio of N-acetylaspartate to creatine and a slight
decrease in that of N-acetylaspartate to choline. The cho-
line:creatine ratio is >1 in tuberculomas,15,16 with a high
peak of lipids, more choline and less N-acetylaspartate and
creatine.
In 2011, 8.7 million people developed TB worldwide. Of
those, 1.1 million (13%) were HIV-positive, and 79% were
in the African Region.12 In 2004, WHO issued recommenda-
tions on the interventions required to prevent, diagnose and
treat TB in people living with HIV, including testing TB
patients for HIV, providing antiretroviral therapy and
co-trimoxazole preventive therapy to TB/HIV patients and
Figure 4: MRI of the brain of patient 9. FLAIR images (A) show high signal intensity in the right parieto-occipital region with
surrounding oedema. Post-gadolinium axial (B) and sagittal (C) views show enhancement.
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providing HIV prevention services for TB patients.12 It also in-
cluded intensifying TB case-finding among people living with
HIV, offering isoniazid preventive therapy to people living
with HIV who do not have active TB, and controlling the
spread of TB infection. Unfortunately, none of our patients
were tested for HIV during the initial work-up.
Biopsy remains the gold standard for diagnosing CNS
tuberculomas. In managing patients at high risk for other
infectious processes or malignancies or those infected with
HIV, there should be a low threshold for brain biopsy for a
definitive diagnosis. In patients who live in or have emigrated
from areas where TB is endemic, early stereotactic needle brain
biopsy may be unnecessary, and empirical therapy may be a
reasonable option. In developed countries, where TB is less
common, a more aggressive approach is probably appropriate,
unless clinical suspicion is high. Because of the reduced
surgical risk, stereotactic brain biopsy is preferred over crani-
otomy. The overall complication rate of stereotactic biopsy
is 0.6–6.3%. When stereotactic biopsy is coupled with paraffin
sectioning, the diagnostic efficacy reaches 85%.17
Surgical treatment of patients with tuberculous meningitis
is directed to the hydrocephalus and tuberculous brain ab-
scesses. Ventriculo-peritoneal or ventriculo-atrial shunts are
permanent measures, which relieve the signs and symptoms
of hydrocephalus and significantly improve the consciousness
level and neurological deficits.18 However, these shunts may
require replacement because of blockage by the high protein
content of the cerebrospinal fluid. Early shunting in combina-
tion with drug therapy offers the best therapeutic outcome.
A single intracranial tuberculoma causing a midline shift
and increased intracranial pressure that fails to respond to
chemotherapy should be removed surgically.19 In chronic
adhesive spinal arachnoiditis, the cerebrospinal fluid locula-
tions may cause cord compression, necessitating surgical
intervention.
Before the development of effective anti-TB therapy, surgi-
cal treatment was the only modality available for treating pa-
tients with intracranial tuberculomas. It was associated with
10% operative mortality and 40% additional mortality due
to postoperative meningitis.20 There have been no randomized
controlled trials to determine which anti-TB regimen is the
most effective in treating CNS tuberculomas.21 In the USA,
the recommended initial therapy is isoniazid, rifampicin,
ethambutol and pyrazinamide until susceptibility to these
drugs is known. If the tubercle bacillus is sensitive, three-drug
therapy with isoniazid, rifampicin and pyrazinamide should be
given for 2 months. Pyrazinamide is then stopped, and isonia-
zid and rifampicin are continued for the rest of the treatment.
It is recommended that CNS tuberculomas be treated for a
minimum of 1 year, or longer if they have developed or pro-
gressed despite treatment.22
The only study in which surgery was compared with drug
therapy for intracranial tuberculomas is that of Harder and
colleagues.23 In their nonrandomized, uncontrolled trial, 20
cases of intracranial tuberculoma were reviewed. Half of
the patients had been treated with isoniazid, ethambutol
and rifampicin, while the other half had undergone excision
of the tuberculoma, followed by the same drug regimen. All
the patients treated with drugs showed resolution of their
tuberculomas by 1 year of treatment, and all patients who
underwent excision were stable by 6 months; however,
patients given drugs were more likely to show improvement
or a return to baseline on a semi-quantitative disability
score. The study has several limitations, including the small
size of the sample and lack of randomization; however, oth-
ers have supported these findings. Most experts in the field
of CNS TB management therefore continue to recommend
medical management as the preferred treatment for intracra-
nial tuberculomas, reserving surgical intervention for patients
who require decompression or biopsy for definitive
diagnosis.
Paradoxical enlargement of a pre-existing tuberculoma or
the appearance of new intracranial or spinal tuberculoma in
patients receiving effective anti-TB therapy is a well-known
phenomenon.24 This immune reconstitution inflammatory
syndrome is thought to be the result of an immunological
reaction, which has variably been attributed to a combination
of the release of new antigen targets during mycobacterial
killing, hypersensitivity to such antigens and exaggerated im-
mune restoration (after TB-induced immunosuppression).
The lesions are usually found on routine follow-up scans or
when new neurological signs develop during medical therapy.
In addition, this phenomenon may develop in patients with
undiagnosed resistance to rifampicin. Drug susceptibility test-
ing (preferably a rapid diagnostic assay) should therefore be
performed in all patients presenting with a paradoxical reac-
tion. Simultaneous steroid administration probably prevents
these focal lesions, although tuberculomas usually resolve
with continuation of anti-TB therapy. In case of unrespon-
siveness to medical therapy, surgery is recommended. Fortu-
nately, none of our patients developed this complication of
therapy.
Table 2: Factors that suggest a non-neoplastic diagnosis in a patient with a space-occupying lesion.
Disease onset in adolescents and young adults (AIDS and other infectious or inflammatory diseases)
History of contact with febrile patients or patients with active tuberculosis
History of travelling to endemic areas (cysticercosis, hydatidosis, amoebiasis)
Intravenous drug addiction or sexual risk behaviour (AIDS, syphilis, brain abscess)
Personal or family history of autoimmune or inflammatory diseases (multiple sclerosis, Behc¸et disease, sarcoidosis)
Recent dental procedure, dental abscess or ear, nose and throat infections (brain abscess)
Immunosuppression, including diabetes (opportunistic infection)
History of recurrent or transient neurological deficits affecting multiple areas in the neuroaxis (multiple sclerosis)
History of oral and genital ulcers and uveites (Behc¸et disease, syphilis)
Presence of oral candidiasis (AIDS, immunosuppression)
Presence of skin rashes (Behc¸et disease, sarcoidosis, AIDS)
Abnormalities on extra-cranial imaging (sarcoidosis, tuberculosis, fungal infections, cysticercosis)
Good control of systemic cancer and absence of lung metastases argues against brain metastases in patients with a history of cancer
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In developing countries in which TB is endemic, CNS mass
lesions caused by TB account for 1.4–8% of all space-occupy-
ing lesions,25,26 while they account for only 0.2% of all such
lesions in industrialized regions. In the absence of extra-cranial
disease, the diagnosis of intracranial TB is difficult and chal-
lenging. Table 2 lists clinical factors that raise the possibility
of a non-neoplastic diagnosis.
Conclusion
CNS TB is a great mimicker of brain tumours, especially in en-
demic areas, where there should be a high index of suspicion.
The diagnosis is based on clinical presentation and the results
of investigations. In patients with CNS TB who present with a
mass lesion, a biopsy should be taken to avoid the morbidity
and mortality associated with unnecessary surgical
interventions.
MRS should be used more widely in evaluating brain-space
occupying lesions, and CNS TB should be included in the dif-
ferential diagnosis of such lesions in all endemic areas, includ-
ing the Kingdom of Saudi Arabia. The absence of
constitutional or pulmonary symptoms of TB is deceptive,
and HIV testing should be done routinely in all cases of sus-
pected CNS TB. More nationwide epidemiological studies
are required to establish guidelines for the early detection
and successful outcome of this condition.
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